40 related articles for article (PubMed ID: 11215378)
1. Exploring traditional and nontraditional roles for thrombomodulin.
Loghmani H; Conway EM
Blood; 2018 Jul; 132(2):148-158. PubMed ID: 29866818
[TBL] [Abstract][Full Text] [Related]
2. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
[TBL] [Abstract][Full Text] [Related]
3. Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo.
Takahashi Y; Hosaka Y; Niina H; Nagasawa K; Naotsuka M; Sakai K; Uemura A
Thromb Haemost; 1995 May; 73(5):805-11. PubMed ID: 7482407
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats.
Uchiba M; Okajima K; Murakami K; Nawa K; Okabe H; Takatsuki K
Thromb Haemost; 1995 Nov; 74(5):1265-70. PubMed ID: 8607107
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats.
Gonda Y; Hirata S; Saitoh K; Aoki Y; Mohri M; Gomi K; Sugihara T; Kiyota T; Yamamoto S; Ishida T
Thromb Res; 1993 Aug; 71(4):325-35. PubMed ID: 8236161
[TBL] [Abstract][Full Text] [Related]
7. [Thrombomodulin].
Ohmori Y; Takahashi Y
Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):283-9. PubMed ID: 11215378
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic evaluation of recombinant thrombomodulin].
Maruyama I
Nihon Rinsho; 1992 Oct; 50(10):2561-7. PubMed ID: 1333021
[TBL] [Abstract][Full Text] [Related]
9. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic strategy of newly developing medicines for disseminated intravascular coagulation--activated protein C and thrombomodulin].
Maruyama I
Nihon Rinsho; 1993 Jan; 51(1):99-106. PubMed ID: 8381887
[TBL] [Abstract][Full Text] [Related]
11. [Soluble thrombomodulin: as a marker of endothelial injury].
Maruyama I; Shinmyozu K
Rinsho Byori; 1994 Jun; 42(6):563-8. PubMed ID: 8051797
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of DIC associated with myelogenous leukemia].
Sakata Y
Nihon Rinsho; 2009 Oct; 67(10):1978-83. PubMed ID: 19860201
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
